$2.64
0.041.54%
Last update: 9:25 AM
15 minutes delayed
Comments
Loading...
Cardiff Oncology
CRDFNASDAQ
Cardiff Oncology (NASDAQ:CRDF) Stock, Earnings Estimates, EPS, And Revenue
Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-0.250
Quarterly Revenue Estimate
$60K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$610K
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology | -$0.25 | -$0.25 | — | — | $108.00K | $60.00K | — | — | 08/07/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.25 | -$0.25 | -$0.22 | 12.00% | $83.00K | $50.00K | $205.00K | 310.00% | 05/02/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.20 | -$0.28 | -$0.21 | 25.00% | $128.00K | $40.00K | $156.00K | 290.00% | 02/29/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.20 | -$0.28 | -$0.22 | 21.43% | $93.00K | $60.00K | $141.00K | 135.00% | 11/02/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.24 | -$0.27 | -$0.25 | 7.41% | $91.00K | $40.00K | $108.00K | 170.00% | 08/09/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.25 | -$0.23 | -$0.25 | -8.70% | $74.00K | $60.00K | $83.00K | 38.33% | 05/04/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.23 | -$0.23 | -$0.20 | 13.04% | $133.00K | $70.00K | $128.00K | 82.86% | 03/02/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.17 | -$0.26 | -$0.20 | 23.08% | $86.00K | $70.00K | $93.00K | 32.86% | 11/03/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.17 | -$0.27 | -$0.24 | 11.11% | $68.00K | $60.00K | $91.00K | 51.67% | 08/04/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.14 | -$0.23 | -$0.25 | -8.70% | $72.00K | $50.00K | $74.00K | 48.00% | 05/05/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.19 | -$0.17 | -$0.23 | -35.29% | $119.00K | $40.00K | $133.00K | 232.50% | 02/24/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.19 | -$0.17 | -$0.17 | 0.00% | $136.00K | $30.00K | $86.00K | 186.67% | 11/04/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.51 | -$0.15 | -$0.17 | -13.33% | $43.00K | $150.00K | $68.00K | -54.67% | 08/05/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.41 | -$0.16 | -$0.14 | 12.50% | $68.00K | $160.00K | $72.00K | -55.00% | 05/06/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.51 | — | -$0.19 | — | $93.00K | — | $119.00K | — | 02/25/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.71 | — | -$0.19 | — | $52.00K | — | $136.00K | — | 11/05/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$0.76 | — | -$0.51 | — | $138.00K | — | $43.00K | — | 08/11/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$1.02 | — | -$0.41 | — | $162.00K | — | $68.00K | — | 05/07/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$1.09 | -$0.65 | -$0.51 | 21.54% | $78.00K | $60.00K | $93.00K | 55.00% | 02/27/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$0.18 | — | -$0.71 | — | $88.00K | — | $52.00K | — | 11/07/2019 | Get Alert |
| CRDF | Cardiff Oncology | -$0.44 | -$0.53 | -$0.79 | -49.06% | $112.00K | $180.00K | $138.00K | -23.33% | 08/08/2019 | Get Alert |
Cardiff Oncology (CRDF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.22 | $-0.25 | 12.0 % |
| Dec 2023 | 2024-02-29 | $-0.21 | $-0.28 | 25.0 % |
| Sep 2023 | 2023-11-02 | $-0.22 | $-0.28 | 21.4 % |
| Jun 2023 | 2023-08-09 | $-0.25 | $-0.27 | 7.41 % |
Cardiff Oncology (CRDF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $205.00K | $50.00K | 310.0 % |
| Dec 2023 | 2024-02-29 | $156.00K | $40.00K | 290.0 % |
| Sep 2023 | 2023-11-02 | $141.00K | $60.00K | 135.0 % |
| Jun 2023 | 2023-08-09 | $108.00K | $40.00K | 170.0 % |
FAQ
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology (CRDF) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Cardiff Oncology (NASDAQ:CRDF)?
The Actual EPS was $-0.22, which beat the estimate of $-0.25.
What were Cardiff Oncology’s (NASDAQ:CRDF) revenues?
The Actual Revenue was $205K, which beat the estimate of $50K.
Browse earnings estimates, EPS, and revenue on all stocks.